Skip to main content
. 2019 May 29;8:212581. doi: 10.7573/dic.212581

Figure 4.

Figure 4

CLEAR 2 study. Proportion of patients achieving a serum UA level of <6.0 mg/dL by month 6 (primary endpoint). Difference between lesinurad 200 mg plus allopurinol group (n=162) versus allopurinol plus placebo group (n=154) was significant (p<0.0001).23

sUA, serum uric acid.